(Q36687440)

15 August 2017

title

Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. (English)

1 reference

15 August 2017

Peyman A

1

1 reference

15 August 2017

Helsberg M

2

1 reference

15 August 2017

Kretzschmar G

3

1 reference

15 August 2017

Mag M

4

1 reference

15 August 2017

Grabley S

5

1 reference

15 August 2017

Uhlmann E

6

1 reference

15 August 2017

language of work or name

1 reference

1 March 1995

1 reference

Biological chemistry Hoppe-Seyler

15 August 2017

published in

1 reference

15 August 2017

volume

376

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

195-198

1 reference

Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Rational screening of oligonucleotide combinatorial libraries for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Inhibition of viral growth by an alpha-oligonucleotide directed to the splice junction of herpes simplex virus type-1 immediate-early pre-mRNA species 22 and 47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Control of ribonucleic acid function by oligonucleoside methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Current concepts in antisense drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

Inhibition of c-Fos Protein Expression in Rat Spinal Cord by Antisense Oligodeoxynucleotide Superfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.195

10.1515/BCHM3.1995.376.3.195

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference